The data presented above point to altered regulation of pyruvate dehydrogenase as mediating breast cancer cell sensitivity to estrogen receptor ligands such as tamoxifen and ICI, and reveal an important role for the serine threonine kinase PDK4 in acquired SERM resistance. Here, MARK2 is linked to breast cancer.